Kim Kramer

6PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission.

Brian H Kushner, Shakeel Modak, Audrey Mauguen

|Apr 11, 2022
Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device.

Sheila S McThenia, Neeta Pandit-Taskar, Milan Grkovski

|Feb 03, 2021
Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.

Kim Kramer, Maria A Donzelli, Melissa S Pessin

|Mar 18, 2019
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.

Kayleen Bailey, Neeta Pandit-Taskar, John L Humm

Pageof 1